Advertisement

Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 600x94px
Organisation › Details

Curetis (Group)

Founded in 2007, Curetis is a molecular diagnostics company which focuses on the development and commercialization of reliable, fast and cost-effective products for diagnosing severe infectious diseases. The diagnostic solutions of Curetis enable rapid multi-parameter pathogen and antibiotic resistance marker detection in only a few hours, a process that today can take up to days or even weeks with other techniques. To date, Curetis has raised EUR 44.3 million in an IPO on Euronext Amsterdam and Euronext Brussels and private equity funds of over EUR 63.5 million. The company is based in Holzgerlingen near Stuttgart, Germany. Curetis has signed collaboration agreements with Heraeus Medical and Cempra Inc. as well as several international distribution agreements covering many countries across Europe, the Middle East and Asia. *

 

Period Start 2007-08-01 established
Products Industry Unyvero molecular diagnostics platform
  Industry 2 Unyvero P50™ pneumonia cartridge
Persons Person Schacht, Oliver (Curetis 201012– CEO before Epigenomics CFO)
  Person 2 Boos, Andreas (Curetis 200812– Managing Director)
     
Region Region Holzgerlingen
  Country Germany
  Street 42 Max-Eyth-Str.
  City 71088 Holzgerlingen
  Tel +49-7031-49195-10
    Address record changed: 2015-11-15
     
Basic data Employees D: 101 to 500 (2017-12-31)
  Currency EUR
  Annual sales 1,187,000 (revenue, consolidated (2017) 2017-12-31)
  Profit -19,498,000 (2017-12-31)
  Cash 16,311,000 (2017-12-31)
     
    * Document for �About Section�: Curetis N.V.. (4/12/16). "Press Release: Curetis Publishes Full-year 2015 Financial Results and Introduces 2016 Guidance". Amsterdam & Holzgerlingen.
     
   
Record changed: 2018-12-18

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

More documents for Curetis (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 600x94px




» top